Skip to content
Dihydrocodeine
Dhc, Synalgos-dc, Synalgos-dc-a (dihydrocodeine) is a small molecule pharmaceutical. Dihydrocodeine was first approved as Synalgos-dc on 1983-09-06. It is used to treat cough and pain in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Aspirin
+
Caffeine
+
Dihydrocodeine bitartrate
Tradename
Company
Number
Date
Products
SYNALGOS-DCSun Pharmaceutical IndustriesN-011483 DISCN1983-09-06
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
trezixANDA2022-05-02
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
coughHP_0012735D003371R05
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AA: Natural opium alkaloid analgesics
— N02AA08: Dihydrocodeine
— N02AA58: Dihydrocodeine, combinations
— N02AJ: Opioids in combination with non-opioid analgesics
— N02AJ01: Dihydrocodeine and paracetamol
— N02AJ02: Dihydrocodeine and acetylsalicylic acid
— N02AJ03: Dihydrocodeine and other non-opioid analgesics
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cystic fibrosisD003550EFO_0000390E84—1———1
SarcomaD012509—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDIHYDROCODEINE
INNdihydrocodeine
Description
Dihydrocodeine is a morphinane alkaloid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314
Identifiers
PDB—
CAS-ID125-28-0
RxCUI23088
ChEMBL IDCHEMBL1595
ChEBI ID—
PubChem CID5284543
DrugBankDB01551
UNII IDN9I9HDB855 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,584 documents
View more details
Safety
Black-box Warning
Black-box warning for: Trezix
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
733 adverse events reported
View more details